-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In 2019, the WHO listed chronic obstructive pulmonary disease (COPD) as the third leading cause of death in the world
Chronic obstructive pulmonary disease (COPD) is a progressive chronic respiratory disease characterized by permanent obstruction of the airway
Previous genetic studies in humans initially linked the disease to the gene encoding the subunit of the nicotinic acetylcholine receptor (nAChR) located on chromosome 15
In animal models carrying this version of the gene, studies have revealed the pathogenesis of emphysema destroying alveolar walls, which is a phenomenon observed in COPD patients
The results of this study were subsequently confirmed in humans
In addition, through in vitro analysis of animal cells expressing modified nicotinic receptors, the signal pathways involved were determined